Literature DB >> 12771629

Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia.

Paola E Cogo1, Luc J I Zimmermann, Roberta Pesavento, Elisabetta Sacchetto, Aldo Burighel, Federica Rosso, Tamara Badon, Giovanna Verlato, Virgilio P Carnielli.   

Abstract

OBJECTIVE: To characterize surfactant kinetics in vivo in two groups of premature infants on different levels of mechanical ventilation and at different risk of developing bronchopulmonary dysplasia.
DESIGN: Controlled observational study in two independent groups of infants.
SETTING: Neonatal intensive care unit. PATIENTS: Thirteen preterm infants (26 +/- 0.5 wks, birth weight 801 +/- 64 g) on high ventilatory setting and who finally all developed bronchopulmonary dysplasia (MechVentBPD), and eight (26 +/- 0.5 wks, birth weight 887 +/- 103 g) who had minimal or no lung disease and of whom none developed bronchopulmonary dysplasia (MechVentNoBPD).
MEASUREMENTS AND MAIN RESULTS: Endotracheal 13C-labeled dipalmitoyl-phosphatidylcholine was administered and subsequent measurements of the 13C enrichment of surfactant-disaturated phosphatidylcholine (DSPC) from serial tracheal aspirates were made by gas chromatography-mass spectrometry. We calculated disaturated phosphatidylcholine pharmacokinetic variables in terms of half-life and apparent pool size from the enrichment decay curves over time. DSPC concentration from tracheal aspirates was expressed as milligrams/milliliter epithelial lining fluid (ELF-DSPC). Data are presented as mean +/- se. In MechVentBPD infants vs. MechVentNoBPD, ELF-DSPC was much reduced, 2.9 +/- 0.6 vs. 9.4 +/- 3.0 mg/mL ELF (p =.03), half-life was shorter, 19.4 +/- 2.8 vs. 42.5 +/- 6.3 hrs (p =.002), and apparent pool size larger, 136 +/- 21 vs. 65.8 +/- 16.0 mg/kg (p =.057). In MechVentBPD, apparent DSPC pool size positively correlated with mean airway pressure x Fio(2) and inversely correlated with ELF-DSPC. ELF-DSPC was inversely correlated with mean airway pressure x Fio(2). No significant correlations were found in the MechVentNoBPD group.
CONCLUSIONS: MechVentBPD infants showed profound alteration of surfactant kinetics compared with preterm infants with minimal lung disease, and these alterations were correlated with severity of ventilatory support.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12771629     DOI: 10.1097/01.CCM.0000063043.25167.99

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Metabolic precursors of surfactant disaturated-phosphatidylcholine in preterms with respiratory distress.

Authors:  Paola E Cogo; Carlo Ori; Manuela Simonato; Giovanna Verlato; Ilena Isak; Aaron Hamvas; Virgilio P Carnielli
Journal:  J Lipid Res       Date:  2009-05-27       Impact factor: 5.922

2.  Surfactant disaturated-phosphatidylcholine kinetics in acute respiratory distress syndrome by stable isotopes and a two compartment model.

Authors:  Paola E Cogo; Gianna Maria Toffolo; Carlo Ori; Andrea Vianello; Marco Chierici; Antonina Gucciardi; Claudio Cobelli; Aldo Baritussio; Virgilio P Carnielli
Journal:  Respir Res       Date:  2007-02-21

3.  In vivo effect of pneumonia on surfactant disaturated-phosphatidylcholine kinetics in newborn infants.

Authors:  Maddalena Facco; Matteo Nespeca; Manuela Simonato; Ilena Isak; Giovanna Verlato; Gianluca Ciambra; Chiara Giorgetti; Virgilio P Carnielli; Paola E Cogo
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

4.  Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice.

Authors:  Jens Madsen; Madhuriben H Panchal; Rose-Marie A Mackay; Mercedes Echaide; Grielof Koster; Giancarlo Aquino; Nicola Pelizzi; Jesus Perez-Gil; Fabrizio Salomone; Howard W Clark; Anthony D Postle
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

Review 5.  What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics.

Authors:  Jasper V Been; Luc J I Zimmermann
Journal:  Eur J Pediatr       Date:  2007-05-22       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.